Future of insulin therapy
Shigeta, Y.; Shichiri, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 31(7): 2232-2238
1973
ISSN/ISBN: 0047-1852 PMID: 4582289 Document Number: 69880
Document emailed within 1 workday
Related Documents
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452Heber, D.; Molitch, M.E.; Sperling, M.A. 1977: Low-dose continuous insulin therapy for diabetic ketoacidosis. Prospective comparison with "conventional" insulin therapy Archives of Internal Medicine 137(10): 1377-1380
Itoh, H.; Namba, M.; Kono, N.; Tarui, S. 1990: Multiple insulin injection therapy as intensive insulin therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1015-1021
Matthaei, S.; Hamann, A. 1997: Current insulin therapy. Treatment with new short-acting and retard insulin analogs Fortschritte der Medizin 115(12): 35-6 39
Bringer, J.; Galtier-Dereure, F.; Augustin-Pascalis, I.; Richard, J.L.; Parer-Richard, C.; Mirouze, J.; Jaffiol, C. 1993: Provisional intensive insulin therapy in non-insulin-dependent diabetes resistant to usual treatment Journees Annuelles de Diabetologie de l'Hotel-Dieu 1993: 115-122
Afanas'eva, S.N. 1982: Insulin therapy and the nature of immunologic reactions to insulin and pancreatic tissue in diabetes mellitus Terapevticheskii Arkhiv 54(10): 30-32
Lundershausen, R.; Potthoff, F.; Häuser, C.; Kaiser, M.; Münscher, C. 2006: Human insulin vs. analogs. What is the cost of supplementary insulin therapy? MMW Fortschritte der Medizin 148(45): 42
Korányi, L.; Tamás, G.; Gerö, L.; Halmos, T.; Baranyai, E.; Büki, B. 1981: Glucagon antibodies in the blood of insulin-treated diabetics (effect of monospecific and monocomponent insulin therapy on antibody level) Orvosi Hetilap 122(23): 1371-1374
King, A. 2012: Advances in insulin therapy: a review of insulin degludec Journal of Family Practice 61(5 Suppl): S28-S31
Mozdzan, M.ł; Mozdzan, M.; Loba, J.; Markuszewski, L.; Ruxer, J. 2006: Effect of short-term intensive insulin therapy on daily insulin requirement in poorly controlled type 2 diabetes patients Wiadomosci Lekarskie 59(3-4): 203-207
Ametov, A.S.; Kochergina, I.I.; Ulanova, K.A. 2010: Effect of insulin therapy on insulin resistance and risk for ischemic heart disease and death from cardiovascular pathology in patients with diabetes mellitus, type 2 Terapevticheskii Arkhiv 82(3): 42-46
Jungmann, E.; Helling, T.; Jungmann, G.; Mertens, C.; Snelting, U. 2001: Intensified conventional insulin therapy in patients with type 2 diabetes mellitus. Positive long-term effects of insulin lispro on metabolic control and microalbuminuria Fortschritte der Medizin. Originalien 118(4): 141-146
Skrha, J. 2013: Present and future of insulin treatment Vnitrni Lekarstvi 59(3): 209-213
Siddiqui, N.I. 2005: Insulin sensitizers: past, present and future Mymensingh Medical Journal: Mmj 14(1): 1-2
Benzi, L.; Marchetti, P.; Carriero, P.L.; Ciccarone, A.M.; Di Cianni, G.; Giannarelli, R.; Giovannitti, M.G.; Navalesi, R. 1987: Long-term therapy with biosynthetic human insulin: importance of short-acting/intermediate-acting insulin ratio on determining efficacy of treatment Drugs under Experimental and Clinical Research 13(5): 321-325
Dirlewanger, M.; Hauschild, M.; Phan-Hug, F.; Schwitzgebel, Vérie.M. 2011: Current and future care for diabetes in children: from insulin to immunotherapy Revue Medicale Suisse 7(283): 430-436
Pfeiffer, E.F.; Kerner, W. 1984: The artificial endocrine pancreas and insulin pumps: past, present and future Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 139(2): 177-187
Cutfield, R.G. 1988: Insulin-dependent diabetes mellitus: current concepts and future trends New Zealand Medical Journal 101(857): 761-763
2005: Individualized therapy. Insulin therapy requirements in pregnancy and old age MMW Fortschritte der Medizin 147(46): 61
Sánchez Sánchez, O.; Sabán Ruiz, Jé. 2008: Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy Medicina Clinica 130(5): 188-196